Steven M. Paul is Director at Sage Therapeutics, Inc. (SAGE). They have made 24 open-market trades across 6 companies since 2006, most recently 2025-09-12.
CIK 0001237564
6 open-market purchases totalling $2.5M since 2014, against 18 sales. Across 6 scored buys the stock is up 1.6% at ninety days, and 1.8 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 17% | 50% | 50% |
| Avg Move | -11.8% | -5.0% | +1.6% |
| Alpha | -10.6% | -5.5% | -1.8% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RAPP | BUY | 2025-09-12 | 2025-09-15 | $24.73 | $1.4M | -3.0% | +0.2% | +15.0% |
| ALNY | SELL | 2022-04-01 | 2022-04-05 | $170.67 | $5.0M | -0.8% | -13.5% | -4.6% |
| KRTX | BUY | 2021-08-17 | 2021-08-18 | $105.86 | $501K | +12.0% | +14.4% | +31.0% |
| ALNY | SELL | 2020-12-18 | 2020-12-22 | $140.00 | $2.1M | -7.8% | +20.6% | +4.2% |
| KRTX | SELL | 2020-06-29 | 2020-06-30 | $103.50 | $60.5M | -19.0% | -26.2% | -30.7% |
| ALNY | SELL | 2020-02-10 | 2020-02-11 | $130.00 | $3.9M | -5.6% | -28.1% | +10.0% |
| KRTX | BUY | 2019-06-28 | 2019-07-01 | $23.04 | $230K | -5.1% | -13.6% | -23.1% |
| SAGE | SELL | 2019-03-21 | 2019-03-22 | $161.04 | $2.5M | +3.3% | +5.7% | +15.7% |
| SAGE | SELL | 2019-03-18 | 2019-03-20 | $161.28 | $19.3M | +3.1% | +8.1% | +19.1% |
| SAGE | SELL | 2019-03-01 | 2019-03-05 | $161.00 | $193K | +5.3% | +7.2% | +12.6% |
| SAGE | SELL | 2019-02-25 | 2019-02-27 | $161.00 | $81K | -1.7% | +0.5% | +10.2% |
| SAGE | SELL | 2019-02-15 | 2019-02-20 | $161.03 | $16.2M | +5.4% | +6.2% | +15.9% |
| SAGE | SELL | 2018-03-06 | 2018-03-08 | $172.00 | $10.0M | -3.0% | -8.9% | -10.2% |
| VYGR | BUY | 2016-01-14 | 2016-01-15 | $14.07 | $141K | -25.8% | -29.7% | -11.8% |
| SAGE | SELL · 10b5-1 | 2015-09-01 | 2015-09-02 | $52.41 | $1.0M | -30.6% | -2.1% | -2.1% |
| SAGE | SELL · 10b5-1 | 2015-08-03 | 2015-08-04 | $67.08 | $1.3M | -30.6% | -2.1% | -2.1% |
| SAGE | SELL · 10b5-1 | 2015-07-01 | 2015-07-02 | $69.40 | $1.4M | -30.6% | -2.1% | -2.1% |
| SAGE | SELL · 10b5-1 | 2015-06-01 | 2015-06-02 | $72.34 | $1.4M | -30.6% | -2.1% | -2.1% |
| BFAM | SELL · 10b5-1 | 2015-05-01 | 2015-05-05 | $53.31 | $1.1M | -7.6% | -1.3% | -1.3% |
| SAGE | SELL | 2015-04-01 | 2015-04-02 | $48.51 | $970K | -30.6% | -2.1% | -2.1% |
| ALNY | BUY | 2015-01-26 | 2015-01-28 | $95.00 | $95K | -18.4% | +0.9% | +0.9% |
| SAGE | BUY | 2014-07-23 | 2014-07-23 | $18.00 | $180K | -30.6% | -2.1% | -2.1% |
| LLY | SELL | 2008-02-04 | 2008-02-05 | $51.60 | $1.0M | -4.9% | -0.6% | -0.6% |
| LLY | SELL · 10b5-1 | 2007-03-12 | 2007-03-13 | $52.39 | $382K | -4.9% | -0.6% | -0.6% |
| LLY | SELL | 2007-02-12 | 2007-02-14 | $54.38 | $396K | -4.9% | -0.6% | -0.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| SIAL |
| 478 |
| — |
| Total | $110.3M |
Shares reported on the most recent Form 4, priced at the 2025-09-15 close. 1 holding could not be priced and is excluded from the total.